Perfinity iDP System
Shimadzu?s the Perfinity iDP* (integrated Digestion Platform) online enzyme digestion HPLC system fully automates all processes from the enzymatic digestion of protein samples to the HPLC analysis of digested peptides.
Perfinity iDP System
Shimadzu’s the Perfinity iDP* (integrated Digestion Platform) online enzyme digestion HPLC system fully automates all processes from the enzymatic digestion of protein samples to the HPLC analysis of digested peptides. The Perfinity iDP uses a high-efficiency immobilized trypsin column for the online enzymatic digestion of proteins, it permits the online enzymatic digestion of proteins in less than one minute. The system iDP improves the analysis throughput by performing parallel processing of the stages from trypsin digestion to concentration in the desalting column and the stages from elution out of the desalting column to HPLC analysis. The easy-to-use software supports method creation and selection for the series of processes from trypsin digestion to desalting and HPLC analysis. An LC/MS can be added as a detector to automate the entire process up to analysis. Compared to conventional manual operations, the iDP offers more uniform control across the board and improves accuracy.
* Perfinity iDP is a registered trademark of Perfinity Biosciences, Inc.
Shimadzu Europa GmbH, Duisburg, Germany.
www.shimadzu.eu[email protected]
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
